List of COVID-19 vaccine authorizations

List of COVID-19 vaccine authorizations
National regulatory authorities have granted full or emergency use authorizations for 40 COVID-19 vaccines.
Ten vaccines have been approved for emergency or full use by at least one stringent regulatory authority recognized by the World Health Organization (WHO): Pfizer–BioNTech, Oxford–AstraZeneca, Sinopharm BIBP, Moderna, Janssen, CoronaVac, Covaxin, Novavax, Convidecia, and Sanofi–GSK. Seven others are under assessment by the WHO: Sputnik V, Sinopharm WIBP, Abdala, Zifivax, Corbevax, COVIran Barekat, and SCB-2019.
Of the 40 vaccines, 16 have a full or emergency authorization in only one country, 12 in ten or fewer countries, and 12 in more than ten countries.
Note that in some countries, vaccines may be authorized solely for travel purposes. They may not be approved for the general population. For example, the CoronaVac, Covishield, BBIBP-CorV and Covaxin vaccines are not part of Australia's national vaccination program; however, they are recognized for the purpose of travel to Australia.
Overview maps
Oxford–AstraZeneca
The Oxford–AstraZeneca COVID-19 vaccine, sold under the brand names Vaxzevria and Covishield, is a viral vector vaccine produced by the British University of Oxford, British-Swedish company AstraZeneca, and the Coalition for Epidemic Preparedness Innovations. Finland, Denmark, and Norway suspended the use of the Oxford–AstraZeneca vaccine due to a small number of reports of a rare blood clot disorder. Slovakia suspended its use after the death of a predisposed recipient. South Africa suspended its use because a small trial found only minimal protection against mild to moderate disease from the locally predominant Beta variant. Japan approved the vaccine for emergency use in May 2021, but did not plan to use them immediately because of rare cases of a blood clotting disorder reported overseas. Later, Japan started to use the vaccine for people aged 40 or over to mitigate the surge of the Delta variant in August. Finland ceased use of the vaccine as the last batch expired on 30 November 2021. Until then it was only offered for those aged 65 or more due to extremely rare coagulation disorders among younger recipients of the vaccine. After this Finland will not procure more of the vaccine. The AstraZeneca vaccine is the most widely accepted internationally, and the most popular in terms of total inoculated worldwide, over 1.3 billion. The AstraZeneca vaccine is administered in more countries than any other vaccine.
Full (5)
Australia
Brazil
Canada
India
Israel
Austria
Belgium
Bulgaria
Croatia
Cyprus
Czech Republic
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Liechtenstein
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
Emergency (170)
Afghanistan
Albania
Algeria
Andorra
Angola
Argentina
Armenia
Azerbaijan
Bahrain
Bangladesh
Benin
Bhutan
Bolivia
Bosnia and Herzegovina
Botswana
Brunei
Burkina Faso
Cambodia
Cameroon
Cape Verde
Central African Republic
Chile
Colombia
Comoros
Congo-Brazzaville
Congo-Kinshasa
Costa Rica
Djibouti
Dominican Republic
East Timor
Ecuador
Egypt
El Salvador
Eswatini
Ethiopia
Fiji
Gambia
Georgia
Ghana
Guatemala
Guinea-Bissau
Guinea
Honduras
Indonesia
Iran
Iraq
Ivory Coast
Japan
Jordan
Kenya
Kiribati
Kosovo
Kuwait
Kyrgyzstan
Laos
Lebanon
Lesotho
Liberia
Libya
Madagascar
Malawi
Malaysia
Maldives
Mali
Mauritania
Mauritius
Mexico
Micronesia
Moldova
Mongolia
Montenegro
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
New Zealand
Nicaragua
Niger
Nigeria
North Macedonia
Oman
Pakistan
Palestine
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Qatar
Rwanda
Samoa
São Tomé and Príncipe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore (restricted)
Solomon Islands
Somalia
South Korea
South Sudan
Sri Lanka
Sudan
Syria
Taiwan
Tajikistan
Thailand
Togo
Tonga
Tunisia
Turkmenistan
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
Uruguay
Uzbekistan
Vanuatu
Vietnam
Yemen
Zambia
Zimbabwe
Antigua and Barbuda
Bahamas
Barbados
Belize
Dominica
Grenada
Guyana
Haiti
Jamaica
Saint Kitts and Nevis
Saint Lucia
Saint Vincent and the Grenadines
Suriname
Trinidad and Tobago
Anguilla
Aruba
British Virgin Islands
Bermuda
Caribbean Netherlands
Cayman Islands
Curaçao
Montserrat
Sint Maarten
Turks and Caicos Islands
Non-country entities
Cook Islands
Falkland Islands
French Polynesia
Greenland
Guadeloupe
Guernsey
Isle of Man
Jersey
Northern Cyprus
Pitcairn
Saint Helena, Ascension and Tristan da Cunha
Wallis and Futuna
World Health Organization
Travel-only
Hong Kong
Switzerland
United States
Austria
Belgium
Bulgaria
Croatia
Cyprus
Czech Republic
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Liechtenstein
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
Pfizer–BioNTech
The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, is an mRNA and Monoclonal vaccine produced by the German company BioNTech and the American company Pfizer. In Hong Kong, Macau, and Taiwan, Comirnaty is distributed by Fosun Pharma.
Original
Full (39)
Australia
Brazil
Canada
Marshall Islands
Micronesia
New Zealand
Palau
Saudi Arabia
Switzerland
Austria
Belgium
Bulgaria
Croatia
Cyprus
Czech Republic
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Liechtenstein
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
Non-country entities
Hong Kong
Emergency (145)
Afghanistan
Albania
Algeria
Andorra
Argentina
Armenia
Azerbaijan
Bahrain
Bangladesh
Benin
Bhutan
Bolivia
Bosnia and Herzegovina
Botswana
Brunei
Cambodia
Cameroon
Cape Verde
Chile
China (For German citizens)
Colombia
Congo-Kinshasa
Costa Rica
Djibouti
Dominican Republic
East Timor
Ecuador
Egypt
El Salvador
Eswatini
Fiji
Gabon
Georgia
Ghana
Guatemala
Guinea
Honduras
Indonesia
Iraq
Israel
Ivory Coast
Japan
Jordan
Kazakhstan
Kenya
Kosovo
Kuwait
Kyrgyzstan
Laos
Lebanon
Libya
Malawi
Malaysia
Maldives
Mexico
Moldova
Monaco
Mongolia
Montenegro
Morocco
Namibia
Nepal
Nicaragua
Nigeria
North Macedonia
Oman
Pakistan
Palestine
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Qatar
Rwanda
Samoa
San Marino
Serbia
Singapore
Somalia
South Africa
South Korea
Sri Lanka
Sudan
Syria
Taiwan
Tajikistan
Tanzania
Thailand
Tonga
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
United Kingdom
Uruguay
Uzbekistan
Vatican City
Vietnam
Yemen
Zambia
Antigua and Barbuda
Bahamas
Barbados
Belize
Dominica
Grenada
Guyana
Haiti
Jamaica
Saint Kitts and Nevis
Saint Lucia
Saint Vincent and the Grenadines
Suriname
Trinidad and Tobago
Anguilla
Aruba
British Virgin Islands
Bermuda
Caribbean Netherlands
Cayman Islands
Curaçao
Montserrat
Sint Maarten
Turks and Caicos Islands
Non-country entities
American Samoa
Cook Islands
Faroe Islands
French Polynesia
Gibraltar
Greenland
Guadeloupe
Guam
Guernsey
Isle of Man
Jersey
Macau
Martinique
New Caledonia
Niue
Northern Cyprus
Northern Mariana Islands
Puerto Rico
Tokelau
World Health Organization
Bivalent original–BA.1
Japan
Austria
Belgium
Bulgaria
Croatia
Cyprus
Czech Republic
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Liechtenstein
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
Non-country entities
World Health Organization
Bivalent original–BA.4/5
Canada
China (For German citizens)
United States
Austria
Belgium
Bulgaria
Croatia
Cyprus
Czech Republic
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Liechtenstein
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
Non-country entities
Hong Kong
Macau
World Health Organization
Janssen
The Janssen COVID-19 vaccine is a viral vector vaccine produced by Janssen Pharmaceutica (a subsidiary of Johnson & Johnson) and Beth Israel Deaconess Medical Center. It is also known as Johnson & Johnson COVID-19 Vaccine and as COVID-19 Vaccine Janssen. Three countries, Denmark, Finland, and Norway, discontinued the use of the Janssen vaccine in favor of other available vaccines due to a possible link between the vaccine and a rare blood clot disorder. The use of the Janssen adenovirus vector vaccine began in Finland in October 2021. It is only offered for those aged 65 and over because of a very rare risk of thrombosis in younger age groups. The United States began use of the Janssen vaccine in March 2021, but discouraged use in favor of other available vaccines in December 2021 due to the risk of a rare clotting disorder. The Janssen vaccine became unavailable in the United States in May 2023 after all existing doses expired.
Full (3)
Australia (not used)
Canada
Switzerland
Emergency (133)
Afghanistan
Andorra
Argentina
Bahamas
Bahrain
Bangladesh
Benin
Bolivia
Botswana
Brazil
Brunei
Burkina Faso
Cambodia
Cameroon
Central African Republic
Chile
Colombia
Congo-Kinshasa
Djibouti
Egypt
Eswatini
Ethiopia
Gabon
Ghana
Guinea
Honduras
India
Indonesia
Iran
Iraq
Ivory Coast
Jordan
Kenya
Kuwait
Laos
Lebanon
Lesotho
Liberia
Libya
Madagascar
Malawi
Malaysia
Maldives
Mali
Marshall Islands
Mauritania
Mexico
Micronesia
Moldova
Monaco
Morocco
Mozambique
Namibia
Nepal
New Zealand
Nicaragua
Nigeria
Oman
Pakistan
Palau
Palestine
Papua New Guinea
Peru
Philippines
Qatar
Rwanda
Saudi Arabia
Senegal
Singapore (restricted)
Somalia
South Africa
South Korea
South Sudan
Sudan
Syria
Taiwan (not used)
Tanzania
Thailand
Tunisia
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States (no longer available as of May 7, 2023 )
Vanuatu
Vietnam
Yemen
Zambia
Zimbabwe
Austria
Belgium
Bulgaria
Croatia
Cyprus
Czech Republic
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Liechtenstein
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
Antigua and Barbuda
Bahamas
Barbados
Belize
Dominica
Grenada
Guyana
Haiti
Jamaica
Saint Kitts and Nevis
Saint Lucia
Saint Vincent and the Grenadines
Suriname
Trinidad and Tobago
Anguilla
Aruba
British Virgin Islands
Bermuda
Caribbean Netherlands
Cayman Islands
Curaçao
Montserrat
Sint Maarten
Turks and Caicos Islands
Non-country entities
American Samoa
French Polynesia
Greenland
Guam
New Caledonia
Northern Cyprus
Northern Mariana Islands
Puerto Rico
Africa Regulatory Taskforce
World Health Organization
Travel-only
Hong Kong
Japan
Turkey
Moderna
The Moderna COVID-19 vaccine, also known as Spikevax, is an mRNA vaccine produced by the American company Moderna, the U.S. National Institute of Allergy and Infectious Diseases, the U.S. Biomedical Advanced Research and Development Authority, and the Coalition for Epidemic Preparedness Innovations. The Moderna vaccine is not offered for men under 30 years of age in Finland as a precaution to reduce a very rare risk of myocarditis.
Original
Full (34)
Australia
Canada
Switzerland
United Kingdom
Austria
Belgium
Bulgaria
Croatia
Cyprus
Czech Republic
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Liechtenstein
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
Emergency (116)
Andorra
Argentina
Armenia
Bahrain
Bangladesh
Bhutan
Botswana
Bolivia
Brazil
Brunei
Cape Verde
Chile
Colombia
Congo-Brazzaville
Congo-Kinshasa
Djibouti
Egypt
El Salvador
Fiji
Ghana
Guatemala
Honduras
India
Indonesia
Iran
Iraq
Israel
Japan
Jordan
Kenya
Kuwait
Kyrgyzstan
Lebanon
Libya
Malawi
Malaysia
Maldives
Marshall Islands
Mexico
Micronesia
Moldova
Monaco
Mongolia
Morocco
Nepal
Nigeria
Oman
Pakistan
Palau
Palestine
Paraguay
Peru
Philippines
Qatar
Rwanda
Saudi Arabia
Serbia
Singapore
South Korea
Sri Lanka
Sudan
Syria
Taiwan
Tajikistan
Thailand
Tunisia
Uganda
Ukraine
United Arab Emirates
Uzbekistan
Vietnam
Yemen
Antigua and Barbuda
Bahamas
Barbados
Belize
Dominica
Grenada
Guyana
Haiti
Jamaica
Saint Kitts and Nevis
Saint Lucia
Saint Vincent and the Grenadines
Suriname
Trinidad and Tobago
Anguilla
Aruba
British Virgin Islands
Bermuda
Caribbean Netherlands
Cayman Islands
Curaçao
Montserrat
Sint Maarten
Turks and Caicos Islands
Non-country entities
American Samoa
Faroe Islands
Greenland
Guadeloupe
Guam
Guernsey
Isle of Man
Jersey
Northern Mariana Islands
Puerto Rico
Wallis and Futuna
World Health Organization
Travel-only
Hong Kong
New Zealand
Turkey
Bivalent original–BA.1
Australia
Canada
Japan
Singapore
Switzerland
Taiwan
United Kingdom
Austria
Belgium
Bulgaria
Croatia
Cyprus
Czech Republic
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Liechtenstein
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
Bivalent original–BA.4/5
Taiwan
United States
Sinopharm BIBP
The Sinopharm BIBP COVID-19 vaccine is an inactivated virus vaccine produced by the China National Pharmaceutical Group (Sinopharm) and its Beijing Institute of Biological Products.
Full (4)
Bahrain
China
Seychelles
United Arab Emirates
Emergency (111)
Afghanistan
Algeria
Angola
Argentina
Armenia
Bangladesh
Belarus
Bhutan
Bolivia
Bosnia and Herzegovina
Brazil
Brunei
Burkina Faso
Burundi
Cambodia
Cameroon
Cape Verde
Chad
Comoros
Congo-Brazzaville
Cuba
Djibouti
Dominican Republic
Egypt
El Salvador
Equatorial Guinea
Ethiopia
Gabon
Gambia
Georgia
Guinea-Bissau
Guinea
Hungary
Indonesia
Iran
Iraq
Ivory Coast
Jordan
Kazakhstan
Kenya
Kiribati
Kuwait
Kyrgyzstan
Laos
Lebanon
Lesotho
Libya
Madagascar
Malawi
Malaysia
Maldives
Mauritania
Mauritius
Mexico
Moldova
Mongolia
Montenegro
Morocco
Mozambique
Myanmar
Namibia
Nepal
Nicaragua
Niger
Nigeria
North Korea
North Macedonia
Oman
Pakistan
Palestine
Papua New Guinea
Paraguay
Peru
Philippines
Qatar
Rwanda
Senegal
Serbia
Sierra Leone
Singapore
Solomon Islands
Somalia
South Sudan
Sri Lanka
Sudan
Syria
Tanzania
Thailand
Tunisia
Turkmenistan
Vanuatu
Venezuela
Vietnam
Yemen
Zambia
Zimbabwe
Antigua and Barbuda
Bahamas
Barbados
Belize
Dominica
Grenada
Guyana
Haiti
Jamaica
Saint Kitts and Nevis
Saint Lucia
Saint Vincent and the Grenadines
Suriname
Trinidad and Tobago
Anguilla
Aruba
British Virgin Islands
Bermuda
Caribbean Netherlands
Cayman Islands
Curaçao
Montserrat
Sint Maarten
Turks and Caicos Islands
Non-country entities
Macau
World Health Organization
Travel-only
Andorra
Australia
Austria (only for entry)
Bulgaria
Canada
Chile
Costa Rica
Croatia
Cyprus
Czech Republic (only for Hungarian citizens and EU nationals vaccinated in Hungary)
Estonia (only if approved in a person's country of origin)
Finland
Greece
Grenada
Hong Kong
Iceland
Ireland
Japan
Latvia
Liechtenstein
New Zealand
Oman
Panama
Portugal (only in Madeira)
Qatar
Saudi Arabia (for short visits, Hajj and Umrah only)
Slovakia
Slovenia
South Korea
Spain
St. Kitts and Nevis
St. Lucia
St. Vincent and the Grenadines
Sweden
Switzerland
The Netherlands
Turkey
Ukraine
United Kingdom
United States
Uruguay (only if approved in a person's country of origin)
Sputnik V
The Sputnik V COVID-19 vaccine is a viral vector vaccine produced by the Russian Gamaleya Research Institute of Epidemiology and Microbiology.
Full (3)
Russia
Turkmenistan
Uzbekistan
Emergency (76)
Albania
Algeria
Angola
Antigua and Barbuda
Argentina
Armenia
Azerbaijan
Bahrain
Bangladesh
Belarus
Bolivia
Bosnia and Herzegovina
Brazil (restricted)
Cambodia
Cameroon
Chile
Congo-Brazzaville
Djibouti
Ecuador
Egypt
Gabon
Gambia
Ghana
Guatemala
Guinea
Guyana
Honduras
Hungary
India
Indonesia
Iran
Iraq
Ivory Coast
Jordan
Kazakhstan
Kenya
Kyrgyzstan
Laos
Lebanon
Libya
Maldives
Mali
Mauritius
Mexico
Moldova
Mongolia
Montenegro
Morocco
Myanmar
Namibia
Nepal
Nicaragua
Nigeria
North Macedonia
Oman
Pakistan
Palestine
Panama
Paraguay
Peru
Philippines
Rwanda
Saint Vincent and the Grenadines
San Marino
Serbia
Seychelles
Sri Lanka
Syria
Tajikistan
Tanzania
Tunisia
Turkey (limited use)
United Arab Emirates
Venezuela
Vietnam
Zimbabwe
Non-country entities
Abkhazia
South Ossetia
Expired
Slovakia
Rejected
South Africa
Travel-only
Australia
Cyprus
Estonia
Greece
Hong Kong
Israel
Malaysia
New Zealand
Saudi Arabia
Slovenia
St. Lucia
Thailand
CoronaVac
The CoronaVac COVID-19 vaccine is an inactivated virus vaccine produced by the Chinese company Sinovac Biotech.
Full (1)
China
Non-country entities
Hong Kong
Emergency (71)
Afghanistan
Albania
Algeria
Argentina
Armenia
Azerbaijan
Bangladesh
Benin
Bolivia
Bosnia and Herzegovina
Botswana
Brazil
Cambodia
Chile
Colombia
Djibouti
Dominica
Dominican Republic
East Timor
Ecuador
Egypt
El Salvador
Equatorial Guinea
Fiji
Gabon
Georgia
Guinea
Guyana
Hungary
Indonesia
Iraq
Jordan
Kazakhstan
Kuwait
Laos
Lebanon
Libya
Malawi
Malaysia
Maldives
Mexico
Moldova
Morocco
Myanmar
Nepal
North Macedonia
Oman
Pakistan
Palestine
Panama
Paraguay
Philippines
Qatar
Rwanda
Saint Vincent and the Grenadines
Saudi Arabia
Singapore
Somalia
South Africa
Sri Lanka
Sudan
Syria
Tajikistan
Tanzania
Thailand
Togo
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Uganda
Ukraine
United Arab Emirates
Uruguay
Uzbekistan
Venezuela
Yemen
Zimbabwe
Non-country entities
Northern Cyprus
World Health Organization
Travel-only
Andorra
Australia
Austria (only for entry)
Canada
Costa Rica
Croatia
Cyprus
Estonia (only if approved in a person's country of origin)
Finland
Greece
Grenada
Iceland
Ireland
Japan
Liechtenstein
Norway
New Zealand
Norway
Palau
Panama
Portugal (only in Madeira)
Slovakia
Slovenia
South Korea
Spain
St. Kitts and Nevis
St. Lucia
St. Vincent and the Grenadines
Sweden
Switzerland
The Netherlands
Ukraine
United Arab Emirates
United Kingdom
United States
Vietnam
Novavax
The Novavax COVID-19 vaccine, sold under the brand names Nuvaxovid and Covovax, is a subunit COVID-19 vaccine candidate developed by Novavax and the Coalition for Epidemic Preparedness Innovations.
Full (4)
Australia
Canada
Japan
South Korea
Emergency (57)
Bangladesh
India
Indonesia
Monaco
New Zealand
Philippines
Singapore
South Africa
Switzerland
Thailand
Taiwan
United Kingdom
United States
Austria
Belgium
Bulgaria
Croatia
Cyprus
Czech Republic
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Liechtenstein
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
Antigua and Barbuda
Bahamas
Barbados
Belize
Dominica
Grenada
Guyana
Haiti
Jamaica
Saint Kitts and Nevis
Saint Lucia
Saint Vincent and the Grenadines
Suriname
Trinidad and Tobago
Anguilla
Aruba
British Virgin Islands
Bermuda
Caribbean Netherlands
Cayman Islands
Curaçao
Montserrat
Sint Maarten
Turks and Caicos Islands
Non-country entities
World Health Organization
Travel-only
Hong Kong
Palau
Panama
Switzerland
Turkey
United Arab Emirates
United States (before emergency approval July 2022)
Covaxin
Covaxin is an inactivated virus vaccine produced by the Indian company Bharat Biotech in collaboration with the Indian Council of Medical Research–National Institute of Virology.
Full (1)
India
Emergency (50)
Afghanistan
Bahrain
Botswana
Central African Republic
Comoros
Egypt
Ethiopia
Guatemala (not used)
Iran
Iraq
Jordan
Kuwait
Lebanon
Libya
Malaysia
Mauritius
Mexico (not used)
Morocco
Myanmar
Nepal
Nicaragua (not used)
Oman
Pakistan
Paraguay
Philippines
Qatar
Somalia
Sudan
Syria
Tunisia
United Arab Emirates
Venezuela (not used)
Vietnam
Yemen
Zimbabwe
Antigua and Barbuda
Bahamas
Barbados
Belize
Dominica
Grenada
Guyana (not used)
Haiti
Jamaica
Saint Kitts and Nevis
Saint Lucia
Saint Vincent and the Grenadines
Suriname
Trinidad and Tobago
Anguilla
Aruba
British Virgin Islands
Bermuda
Caribbean Netherlands
Cayman Islands
Curaçao
Montserrat
Sint Maarten
Turks and Caicos Islands
Non-country entities
Palestine
World Health Organization
Travel-only
Andorra
Australia
Austria (only for entry)
Canada
Costa Rica
Croatia
Cyprus
Estonia (only if approved in a person's country of origin)
Finland
Greece
Hong Kong
Iceland
Ireland
Japan
Kyrgyzstan
Liechtenstein
Mongolia
New Zealand
Norway
Oman
Palestine
Palau
Panama
Portugal (only in Madeira)
Saudi Arabia
Singapore
Slovakia
Slovenia
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Thailand
The Netherlands
Turkey
Ukraine
United Kingdom
United States
VLA2001
VLA2001 is an inactivated vaccine developed by Valneva SE and Dynavax Technologies.
Full (1)
United Kingdom
Emergency (32)
Bahrain
United Arab Emirates
Austria
Belgium
Bulgaria
Croatia
Cyprus
Czech Republic
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Liechtenstein
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
Travel-only
Malaysia
New Zealand
Turkey
Sanofi–GSK
The Sanofi–GSK COVID-19 vaccine, sold under the brand name VidPrevtyn Beta, is a subunit vaccine developed by Sanofi Pasteur and GSK plc. It is based on the SARS-CoV-2 Beta variant.
(as booster only)
Austria
Belgium
Bulgaria
Croatia
Cyprus
Czech Republic
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Liechtenstein
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
Sputnik Light
Sputnik Light is a viral vector vaccine, produced by the Russian Gamaleya Research Institute of Epidemiology and Microbiology. It consists of the first dose of the Sputnik V vaccine, which is based on the Ad26 vector.
Full (0)
Emergency (28)
Angola
Argentina
Armenia
Bahrain
Belarus
Benin
Cambodia
Congo-Brazzaville
Egypt
Iran
India
Kazakhstan
Kyrgyzstan
Laos
Mauritius
Mongolia
Nicaragua
Palestine
Philippines
Russia
Saint Vincent and the Grenadines
San Marino
Syria
Tanzania
Tunisia
TurkmenistanТуркменистан зарегистрировал облегченный вариант российской вакцины «Спутник V»
United Arab Emirates
Venezuela
Non-country entities
Abkhazia
Donbass Region (unofficially)
Travel-only
Malaysia
New Zealand
Turkey
Convidecia
Convidecia is a viral vector vaccine produced by the Chinese company CanSino Biologics and the Beijing Institute of Biotechnology of the Academy of Military Medical Sciences.
Full (1)
China
Emergency (9)
Argentina
Chile
Ecuador
Hungary
Indonesia
Malaysia
Mexico
Moldova
Pakistan
Non-country entities
World Health Organization
Travel-only
Hong Kong
Japan
New Zealand
Turkey
Sinopharm WIBP
The Sinopharm WIBP COVID-19 vaccine is an inactivated virus vaccine produced by the China National Pharmaceutical Group (Sinopharm) and its Wuhan Institute of Biological Products.
Full (1)
China
Emergency (5)
Armenia
North Macedonia
Peru
Philippines
United Arab Emirates
Venezuela
Travel-only
Hong Kong
Malaysia
New Zealand
Turkey
Abdala
Abdala is a subunit vaccine developed by the Center for Genetic Engineering and Biotechnology in Cuba.
Full (0)
Emergency (6)
Cuba
Mexico
Nicaragua
St. Vincent and the Grenadines
Venezuela
Vietnam
Travel-only
Cambodia
Colombia
Guyana
Malaysia
New Zealand
St. Lucia
Turkey
Uruguay (only if accepted in the country of the person's origin)
EpiVacCorona
EpiVacCorona is a peptide vaccine produced by the Russian State Research Center of Virology and Biotechnology VECTOR.
Full (1)
Turkmenistan
Emergency (4)
Belarus
Cambodia
Russia
Venezuela
Travel-only
Malaysia
New Zealand
Turkey
Zifivax
Zifivax is a subunit vaccine produced by the Chinese company Anhui Zhifei Longcom Biopharmaceutical.
Full (0)
Emergency (5)
China
Colombia
Indonesia
Pakistan
Uzbekistan
Travel-only
Hong Kong
Malaysia
New Zealand
Turkey
Soberana 02
Soberana 02, is a conjugate vaccine developed by the Finlay Institute in Cuba.
Full (0)
Emergency (4)
Cuba
Iran
Nicaragua
Venezuela
Travel-only
Guyana
Hungary
Malaysia
New Zealand
Turkey
CoviVac
CoviVac is an inactivated virus vaccine produced by the Chumakov Centre at the Russian Academy of Sciences.
Full (0)
Emergency (3)
Belarus
Cambodia
Russia
Travel-only
Malaysia
New Zealand
Turkey
QazCovid-in
QazCovid-in, also known as QazVac, is an inactivated virus vaccine developed by the Research Institute for Biological Safety Problems in Kazakhstan.
Full (0)
Emergency (2)
Kazakhstan
Kyrgyzstan
Travel-only
Malaysia
New Zealand
Turkey
Minhai
Minhai COVID-19 vaccine, is an inactivated virus vaccine developed by Minhai Biotechnology Co. and Shenzhen Kangtai Biological Products Co. Ltd. in China.
Full (0)
Emergency (2)
China
Indonesia
Travel-only
Hong Kong
Malaysia
New Zealand
Turkey
Medigen
MVC-COV1901, is a protein subunit vaccine developed by Taiwan's Medigen Vaccine Biologics and Dynavax Technologies.
Full (0)
Emergency (3)
Eswatini
Taiwan
Paraguay
Non-country entities
1. Somaliland
Travel-only
Belize
Indonesia
Malaysia
New Zealand
Palau
Thailand
Turkey
Corbevax
Corbevax is a protein subunit vaccine developed by Texas Children's Hospital at the Baylor College of Medicine in Houston, Texas, and licensed to Indian biopharmaceutical firm Biological E. Limited (BioE) for development and production.
Full (0)
Emergency (2)
India
Botswana
Travel-only
Malaysia
New Zealand
Turkey
COVIran Barekat
COVIran Barekat, is an inactivated virus vaccine developed by Shifa Pharmed Industrial Co. in Iran.
Full (0)
Emergency (2)
Iran
Nicaragua
Travel-only
Malaysia
New Zealand
Hungary
Turkey
Chinese Academy of Medical Sciences
Chinese Academy of Medical Sciences COVID-19 vaccine, is an inactivated virus vaccine developed by Chinese Academy of Medical Sciences.
Full (0)
Emergency (1)
China
Travel-only
Hong Kong
New Zealand
Turkey
ZyCoV-D
ZyCoV-D, is a DNA plasmid based COVID-19 vaccine developed by the Indian pharmaceutical company Cadila Healthcare with support from the Biotechnology Industry Research Assistance Council.
Full (0)
Emergency (1)
India
Travel-only
Malaysia
New Zealand
Turkey
FAKHRAVAC
FAKHRAVAC (or MIVAC), is an inactivated virus vaccine developed in Iran by the Organization of Defensive Innovation and Research, an organization of Iran's Ministry of Defense.
Full (0)
Emergency (1)
Iran
Travel-only
Hungary
Malaysia
New Zealand
Turkey
COVAX-19
COVAX-19, also known as SpikoGen, is a protein subunit vaccine jointly developed by Australian-based company Vaxine and Iran-based company CinnaGen.
Full (0)
Emergency (1)
Iran
Travel-only
Hungary
Malaysia
New Zealand
Turkey
Razi Cov Pars
Razi Cov Pars is a protein subunit vaccine developed by Razi Vaccine and Serum Research Institute.
Full (0)
Emergency (1)
Iran
Travel-only
Hungary
Malaysia
New Zealand
Turkey
Turkovac
Turkovac is an inactivated vaccine developed by Health Institutes of Turkey and Erciyes University.
Full (0)
Emergency (1)
Turkey
Travel-only
Malaysia
New Zealand
Sinopharm CNBG
Sinopharm CNBG COVID-19 vaccine (NVSI) is a recombinant protein subunit vaccine developed by the National Vaccine & Serum Institute (NVSI, 中生研究院), a subsidiary of China National Biotec Group (CNBG), which in turn is a subsidiary of Sinopharm.
Full (0)
Emergency (1)
United Arab Emirates
Travel-only
Malaysia
Turkey
Soberana Plus
Soberana Plus is a single-dose of conjugate vaccine developed by the Finlay Institute in Cuba.
Full (0)
Emergency (2)
Belarus
Cuba
Travel-only
Guyana
Malaysia
New Zealand
Turkey
CoVLP
CoVLP is a virus-like particle vaccine grown in an Australian weed, Nicotiana benthamiana. It was developed by Medicago, and is marketed under the name Covifenz .
Full (1)
Canada
Emergency (0)
Travel-only
Malaysia
New Zealand
Turkey
Noora
Noora is a protein-based vaccine developed by the Baqiyatallah University of Medical Sciences.
Full (0)
Emergency (1)
Iran
Travel-only
Malaysia
Turkey
SKYCovione
SKYCovione is a protein subunit vaccine developed by SK Bioscience.
Full (0)
Emergency (1)
South Korea
Walvax
Walvax COVID-19 vaccine is an RNA vaccine developed by Walvax Biotechnology, Suzhou Abogen Biosciences, and the PLA Academy of Military Science.
Full (0)
Emergency (1)
Indonesia
iNCOVACC
iNCOVACC, also called BBV154 is an adenovirus vector vaccine developed by Bharat Biotech, Precision Virologics, and Washington University School of Medicine.
Full (0)
Emergency (1)
India
Gemcovac
Gemcovac, or GEMCOVAC-19, is a self-amplifying mRNA vaccine manufactured by Gennova Biopharmaceuticals.
Full (0)
Emergency (1)
India
V-01
V-01 is a protein subunit vaccine developed by Livzon Mabpharm.
Full (0)
Emergency (1)
China
IndoVac
IndoVac is a protein subunit vaccine developed by Indonesian pharmaceutical company Bio Farma and Baylor College of Medicine.
Full (0)
Emergency (1)
Indonesia
Notes
References
Medical research